Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
PaperCitations, authors & open-access status
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,714 citations, 2020 year and bronze oa status.
1,714
Citations
2020
Year
bronze
OA Status